ESC 365 - HUYGENS: Evolocumab and changes in plaque composition on OCT

ESC Premium Access

HUYGENS: Evolocumab and changes in plaque composition on OCT

Session: Late Breaking Trials in ACS

Topic: Pharmacotherapy

Speaker: Professor S. Nicholls (Melbourne, AU)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Professor Stephen Nicholls

Monash University, Melbourne (Australia)

53 presentations

5 followers

3 more presentations in this session

QUORUM : Quantum Genomics Firibastat (QGC001) or Ramipril after Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction

Speaker: Professor G. Montalescot (Paris, FR)

ACCOST-HH: Adrecizumab in cardiogenic shock

Speaker: Doctor M. Karakas (Hamburg, DE)

Low-dose rivaroxaban during the acute phase of ACS - H-REPLACE Trial)

Speaker: Professor S. Zhou (Changsha, CN)

Access the full session

Late Breaking Trials in ACS

Speakers: Professor S. Nicholls, Professor G. Montalescot, Doctor M. Karakas, Professor S. Zhou

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources